Nicotine use is responsible for 26,500 emergency room visits per year and may play a role in nearly 193,000 other visits. Targeted policies could significantly reduce the pressure on emergency care.
Recent trials show that the PanFlu nasal spray, developed by Leyden Labs, is showing promising results and has the potential to be used as a preventive tool against new pandemics.
Leiden plays a key role in the future earning capacity of the Netherlands. With leading knowledge institutions and the Leiden Bio Science Park, the city connects science, entrepeneurship and impact, making it a strong location for international congresses
Researchers at the LUMC have tested the drug IC7Fc, which combats cardiovascular disease. The drug could be an important breakthrough and step forward in the fight against cardiovascular disease, which kills 17 million people worldwide every year.
The LUMC is collaborating with KickstartAI to develop a new AI model that assists nurses in creating wound reports. The model can generate a wound report based on photographs of the wound.
The LUMC has developed a device for babies in the NICU who experience apnoea. Apnoea is a brief interruption in breathing, which can have dangerous consequences such as brain damage.